Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.19.3
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Concentration Risk [Line Items]        
Revenues $ 91,761 $ 95,291 $ 283,026 $ 271,580
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 73,269 74,149 222,167 212,773
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 18,492 $ 21,142 $ 60,859 $ 58,807